Edition:
India

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

42.11USD
19 Jan 2018
Change (% chg)

$-0.68 (-1.59%)
Prev Close
$42.79
Open
$42.52
Day's High
$42.85
Day's Low
$42.08
Volume
18,130
Avg. Vol
7,290
52-wk High
$58.36
52-wk Low
$41.95

Chart for

About

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of... (more)

Overall

Beta: 1.67
Market Cap(Mil.): $350.55
Shares Outstanding(Mil.): 7.16
Dividend: --
Yield (%): --

Financials

BRIEF-Biospecifics Technologies reports Q3 eps of $0.37

* Biospecifics Technologies Corp reports Q3 2017 financial results

10 Nov 2017

BRIEF-BioSpecifics Technologies reports Q2 earnings per share $0.36

* BioSpecifics Technologies Corp reports second quarter 2017 financial results

10 Aug 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $147.36 +0.44
Novartis AG (NOVN.S) CHF83.38 +0.48
Pfizer Inc. (PFE.N) $36.94 -0.05
Roche Holding Ltd. (ROG.S) CHF234.50 +1.30
Roche Holding Ltd. (RO.S) CHF237.80 +1.00
Merck & Co., Inc. (MRK.N) $61.28 +0.15
Bayer AG (BAYGn.DE) €104.08 +0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.95 +0.58
GlaxoSmithKline plc (GSK.L) 1,358.00 +4.80

Earnings vs. Estimates